SCHEMBL1448482

SCHEMBL1448482

Cc1ccc(Cn2cc(F)c(N=CN(C)C)nc2=O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
TP53 P04637 2/20 0.38
MAPT P10636 2/20 0.38
THRB P10828 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
RXFP1 Q9HBX9 2/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HTT P42858 1/20 0.34
P2RX7 Q99572 2/20 0.34
HTR6 P50406 1/20 0.34
HPGD P15428 1/20 0.33
PDE5A O76074 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1448481 1.00 KMT2A (0.45) KMT2AMEN1TP53MAPTTHRB
SCHEMBL12741701 1.00 KMT2A (0.45) KMT2AMEN1TP53MAPTTHRB
SCHEMBL1448459 0.92 MEN1 (0.51) KMT2AMEN1TP53MAPTTHRB
SCHEMBL12741607 0.92 MEN1 (0.51) KMT2AMEN1TP53MAPTTHRB
SCHEMBL1448460 0.92 MEN1 (0.51) KMT2AMEN1TP53MAPTTHRB
SCHEMBL12741699 0.89 HPGD (0.44) KMT2AMEN1MAPTNPSR1KDM4E
SCHEMBL12741742 0.87 MEN1 (0.42) KMT2AMEN1NPSR1L3MBTL1P2RX7
SCHEMBL1448445 0.81 MEN1 (0.35) KMT2AMEN1MAPTKDM4EALDH1A1
SCHEMBL1448444 0.81 MEN1 (0.35) KMT2AMEN1MAPTKDM4EALDH1A1
SCHEMBL12900485 0.80 MEN1 (0.38) KMT2AMEN1NPSR1L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170008855-A1 5-FLUOROPYRIMIDINONE DERIVATIVES ADAMA MAKHTESHIM LTD. (IL) 2017-01-12 US disclosed
US-20150111851-A1 5-FLUOROPYRIMIDINONE DERIVATIVES ADAMA MAKHTESHIM LTD. (IL) 2015-04-23 US disclosed
US-8916579-B2 5-fluoropyrimidinone derivatives DOW AGROSCIENCES, LLC. (US) 2014-12-23 US disclosed
US-20110053891-A1 5-FLUOROPYRIMIDINONE DERIVATIVES DOW AGROSCIENCES LLC (US) 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170008855-A1 5-FLUOROPYRIMIDINONE DERIVATIVES DDT, CASP5, CYP3A5 KMT2A 3314/4885MEN1 2898/4885TP53 2303/4885
US-20150111851-A1 5-FLUOROPYRIMIDINONE DERIVATIVES DDT, CASP5, CYP3A5 KMT2A 3314/4885MEN1 2898/4885TP53 2303/4885
US-20110053891-A1 5-FLUOROPYRIMIDINONE DERIVATIVES DDT, CASP5, CYP3A5 KMT2A 3314/4885MEN1 2898/4885TP53 2303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.